Highlights Sera Prognostics, Inc.

Equities

SERA

US81749D1072

Delayed Nasdaq Other stock markets 20:55:09 08/05/2024 BST			5-day change	1st Jan Change
9.435 ^USD	-0.47%		-9.35%	+58.11%

03-28	Sera Prognostics Insider Sold Shares Worth $727,853, According to a Recent SEC Filing	MT
03-27	Sera Prognostics Insider Sold Shares Worth $364,484, According to a Recent SEC Filing	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (SERA) SERA PROGNOSTICS Posts Q4 Revenue $41,000	03-20	MT
Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-20	CI
Sera Prognostics Inc. Announces Preliminary Efficacy Met in Pivotal Prime Study Interim Look - Enrollment to Stop Due to Success	12-06	CI
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $42,000	11-08	MT
Sera Prognostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Earnings Flash (SERA) SERA PROGNOSTICS Reports Q2 Revenue $123,000	09/08/23	MT
Sera Prognostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23	CI
Earnings Flash (SERA) SERA PROGNOSTICS Reports Q1 Revenue $100,000	10/05/23	MT
Sera Prognostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23	CI
Earnings Flash (SERA) SERA PROGNOSTICS Reports Q4 Revenue $65,000	22/03/23	MT
SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22/03/23	AQ
Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	22/03/23	CI
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	22/03/23	CI
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	22/03/23	CI
Sera Prognostics, Inc. Announces Positive Top-Line Data from AVERT PRETERM TRIAL	15/02/23	CI
Sera Prognostics, Inc. Announces Publication of Data Predicting Clinical Utility and Cost Effectiveness of the Pretrm® Test-And-Treat Strategy Across Diverse Populations	15/11/22	CI
SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	09/11/22	AQ
Sera Prognostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22	CI
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $87,000	09/11/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sera Prognostics, Inc.

Equities

SERA

US81749D1072

Highlights

Filters